Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00071656 · ClinicalTrials.gov registry record · NA
Psychosocial Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Type I
A NA study of Attention Deficit Disorder With Hyperactivity, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT00071656: Completed NA study of Attention Deficit Disorder With Hyperactivity, sponsored by University of California, San Francisco.
NCT00071656 is a NA study of Attention Deficit Disorder With Hyperactivity that has completed, run by University of California, San Francisco. The registered enrollment target is 60 participants, below the 352-participant average among 20 other Attention Deficit Disorder With Hyperactivity trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00071656, a NA study of Attention Deficit Disorder With Hyperactivity, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to develop and implement a treatment that focuses on behaviors to reduce symptom severity and functional impairment in patients with Attention Deficit Hyperactivity Disorder, Predominantly Inattentive Type (ADHD-I). The long-term goal of this study is to apply the treatment to larger-scale trials to determine its effectiveness and generalizability.
Conditions Studied
Interventions
- BEHAVIORAL Psychosocial (behavioral) Intervention
Study Locations (1)
California
- HALP Clinic, Children's Center at Langley Porter, UCSF - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2002-09 |
| Est. Completion | 2007-06 |
| Phase | NA |
What the finished NCT00071656 record still lists
NCT00071656 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 352-participant average among 20 other Attention Deficit Disorder With Hyperactivity trials with a reported enrollment target (83% lower).
The record links to 1 condition, with Attention Deficit Disorder With Hyperactivity appearing as the primary indexed condition, and to 1 intervention - of which Psychosocial (behavioral) Intervention is the first listed.
NCT00071656 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00071656 about?
NCT00071656 is a clinical study titled "Psychosocial Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Type I". The purpose of this study is to develop and implement a treatment that focuses on behaviors to reduce symptom severity and functional impairment in patients with Attention Deficit Hyperactivity Disorder, Predominantly Inattentive Type (ADHD-I). The long-term goal of this study is to apply the treatm...
What is the current status of trial NCT00071656?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2002-09. Estimated completion is 2007-06.
What conditions does trial NCT00071656 study?
This clinical trial studies the following conditions: Attention Deficit Disorder With Hyperactivity.
What interventions are being tested in trial NCT00071656?
The interventions under investigation include: Psychosocial (behavioral) Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00071656?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00071656 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Attention Deficit Disorder With Hyperactivity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00071656's enrollment target sits among peer trials
60 15th of 20 higher than 5 of 20 other Attention Deficit Disorder With Hyperactivity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Attention Deficit Disorder With Hyperactivity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Home-based Transcranial Direct Current Stimulation (tDCS) for Treatment of Attention-deficit/Hyperactivity Disorder (ADHD)
RECRUITING · NA
-
Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD)
COMPLETED · NA
-
Psychosocial Treatment for Attention Deficit Hyperactivity Disorder in Adults
COMPLETED · NA
-
Software Treatment for Actively Reducing Severity of ADHD
COMPLETED · NA
-
Children's Attention Deficit Disorder With Hyperactivity (ADHD) Telemental Health Treatment Study
COMPLETED · NA
-
Organizational Skills Training for Children With Attention Deficit Hyperactivity Disorder
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia